NYKODE THERAPEUTICS AS (VACBF, $0.22) was a top loser over the last three months, falling -3 to $0.22 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry for the 3-month period ending February 19, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.